- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02907450
TolTwiCare : Qualitative Evaluation Routine Care From Primary Tolerance of a Prefabricated and Removable Orthosis (TolTwiCare)
The TwiCare® device is a removable brace that can be used in orthopedic referred to stimulate mandibular growth or in interception / contention.
The proposed research project will focus initially on assessing the comfort and safety of TwiCare® device. The orthopedic efficiency therefore not part of this study.
The comfort and safety of the brace will be evaluated firstly by the practitioner during the visit control around 2 ½ months (or 11 weeks) after the start of the port of the device, and with the help of a questionnaire completed by the patient at home 3 weeks and 6 weeks after the start of the port of the device, and during the control visit at 11 weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44093
- CHU de Nantes -Service d'Odontologie Restauratrice et Chirurgicale
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male or female patients, where the laying of a brace phase of interception or contention after dental-facial orthodontic treatment is indicated (an intended age range of 8-18 years, not exhaustive or limiting) , recipient of a social security scheme, for which a management of the orthosis is acquired.
- incisor width compatible with the sizes of TwiCare® orthotics available, according to manufacturer's recommendations
- patient in good general health
- parent or guardian able to receive clear information, and express their opposition not to the patient's participation in this research
- for patients with malocclusions, the incisors (maxillary and mandibular) should be aligned.
Exclusion Criteria:
- General chronic health problem, unbalanced
- obvious oral ventilation
- history of temporomandibular dysfunction
- nocturnal episodes of severe bruxism
- unbalanced periodontal disease
- allergies or intolerances known to one of the constituents of the orthosis
- opposition of representatives of the parental authority (parent or guardian) or the patient himself at the patient's participation in this research
- patient unable to respond to the questionnaire
- monitoring difficulties (going on holiday, imminent change, remoteness, lack of motivation)
- simultaneous participation in intervention research
- pregnant Patient on examination of the latter, according to his age
- Incisive (maxilla and / or mandible) unaligned
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Clinical evaluation of the tolerance of the orthosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
No appearance of more than one injury that can not be attributed to causes other than the orthosis
Time Frame: 11 weeks
|
11 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The clinical evaluation of the compliance of the orthosis (occurrence of tooth movement, state of the brace, usual patient interview)
Time Frame: 11 weeks
|
11 weeks
|
|
The subjective assessment of the compliance of wearing the brace by patient by self questionnaire
Time Frame: 11 weeks
|
11 weeks
|
|
The subjective assessment of patient acceptability questionnaires self treatment
Time Frame: 11 weeks
|
11 weeks
|
|
The support type envisaged endline by the doctor
Time Frame: 11 weeks
|
11 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BRD/11/2-W
- 2011-A01106-35 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dentofacial Functional Disorder
-
Medical University of GrazRecruitingFunctional Neurological Disorder | Functional Movement DisorderAustria
-
King's College Hospital NHS TrustRecruiting
-
University of North Carolina, Chapel HillNorth Carolina State UniversityRecruitingMalocclusion | Speech Disorders | Speech Sound Disorder | Dentofacial Deformities | Skeletal Malocclusion | Dentofacial Anomalies, Including Malocclusion | Dentofacial Abnormalities | Malocclusion in Children | Dentofacial Disharmony | Skeletal MalformationUnited States
-
University of VirginiaChild Neurology FoundationActive, not recruitingFunctional Neurological Symptom Disorder | Functional Neurological Disorder | Functional Movement DisorderUnited States
-
University Hospital Schleswig-HolsteinCompletedFunctional Blood Flow DisorderGermany
-
South West London and St George's Mental Health...CompletedFunctional Neurological Symptom DisorderUnited Kingdom
-
University Hospital, Basel, SwitzerlandRecruitingFunctional Neurological DisorderSwitzerland
-
Fundación Pública Andaluza para la gestión de la...Fundación CaserCompletedFunctional Neurological Disorder | Functional Movement DisorderSpain
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
-
Western University, CanadaNot yet recruitingFunctional Movement DisorderCanada
Clinical Trials on TwiCare®.
-
FCI SystemTerminatedMalocclusion, Angle Class II, Division 1France
-
Galderma R&DCompletedAtopic DermatitisPhilippines, China
-
Dong-A ST Co., Ltd.CompletedFunctional DyspepsiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Diphtheria | PolioUnited States
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownFunctional DyspepsiaKorea, Republic of
-
Amir AzarpazhoohInstitut Straumann AGCompletedPeriodontal Inflammation | Crown LengtheningCanada
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic Obstructive (COPD)Argentina
-
GuerbetCompletedPrimary Brain TumorColombia, Korea, Republic of, United States, Mexico